订阅小程序
旧版功能

A Randomized Controlled Trial Comparing PF-06438179/GP1111 (an Infliximab Biosimilar) and Infliximab Reference Product for Treatment of Moderate to Severe Active Rheumatoid Arthritis Despite Methotrexate Therapy

Stanley B. Cohen,Rieke Alten,Hideto Kameda,Tomas Hala,Sebastiao C. Radominski,Muhammad I. Rehman,Ramesh Palaparthy,Karl Schumacher,Susanne Schmitt,Steven Y. Hua,Claudia Ianos,K. Lea Sewell

Arthritis Research & Therapy（2018）

引用 52|浏览27
关键词
Infliximab,PF-06438179/GP1111,Biosimilar,Rheumatoid arthritis,Dose escalation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要